Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The company initiated a share repurchase program on February 4, 2026, intending to repurchase up to DKK 15 billion in shares over a 12-month period. As of April 1, 2026, Novo Nordisk has repurchased 9,967,992 B shares, with a transaction value of DKK 2,586,404,548, averaging DKK 259.47 per share. The company currently holds 27,357,791 B shares as treasury shares, representing 0.6% of the total share capital. The program operates under European regulations MAR and the Safe Harbour Rules. Specific transaction details are available on the company's website. Novo Nordisk is a global healthcare company focused on chronic diseases, with operations in 80 countries.